Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Offringa, M; Moyer, VA
   Evidence based paediatrics - Evidence based management of seizures associated with fever
   BRITISH MEDICAL JOURNAL
   
   M. Offringa e V.A. Moyer, "Evidence based paediatrics - Evidence based management of seizures associated with fever", BR MED J, 323(7321), 2001, pp. 1111-1114
2. Kremer, LCM; van Dalen, EC; Offringa, M; Ottenkamp, J; Voute, PA
   Anthracycline-induced clinical heart failure in a cohort of 607 children: Long-term follow-up study
   JOURNAL OF CLINICAL ONCOLOGY
   
   L.C.M. Kremer et al., "Anthracycline-induced clinical heart failure in a cohort of 607 children: Long-term follow-up study", J CL ONCOL, 19(1), 2001, pp. 191-196
3. Offringa, M; Moyer, VA
   An evidence-based approach to managing seizures associated with fever in children
   WESTERN JOURNAL OF MEDICINE
   
   M. Offringa e V.A. Moyer, "An evidence-based approach to managing seizures associated with fever in children", WEST J MED, 175(4), 2001, pp. 254-259
4. Coutinho, HM; Groothoff, JW; Offringa, M; Gruppen, MP; Heymans, HSA
   De novo malignancy after paediatric renal replacement therapy
   ARCHIVES OF DISEASE IN CHILDHOOD
   
   H.M. Coutinho et al., "De novo malignancy after paediatric renal replacement therapy", ARCH DIS CH, 85(6), 2001, pp. 478-483
5. van Karnebeek, CDM; Naeff, MSJ; Mulder, BJM; Hennekam, RCM; Offringa, M
   Natural history of cardiovascular manifestations in Marfan syndrome
   ARCHIVES OF DISEASE IN CHILDHOOD
   
   C.D.M. van Karnebeek et al., "Natural history of cardiovascular manifestations in Marfan syndrome", ARCH DIS CH, 84(2), 2001, pp. 129-137
6. de Kraker, J; Bierings, MB; Offringa, M
   Letter to the Editor: Lack of protection of proximal tubular cells by amofostine (Ethyol) in ifosfamide-containing regimens
   MEDICAL AND PEDIATRIC ONCOLOGY
   
   J. de Kraker et al., "Letter to the Editor: Lack of protection of proximal tubular cells by amofostine (Ethyol) in ifosfamide-containing regimens", MED PED ONC, 34(1), 2000, pp. 78-79
7. Kremer, LCM; Tiel-van Buul, MMC; Ubbink, MC; Offringa, M; Ottenkamp, J; Olmos, RV; Voute, PA
   Indium-111-antimyosin scintigraphy in the early detection of heart damage after anthracycline therapy in children
   JOURNAL OF CLINICAL ONCOLOGY
   
   L.C.M. Kremer et al., "Indium-111-antimyosin scintigraphy in the early detection of heart damage after anthracycline therapy in children", J CL ONCOL, 17(4), 1999, pp. 1208-1211
8. Cools, F; Offringa, M
   Meta-analysis of elective high frequency ventilation in preterm infants with respiratory distress syndrome
   ARCHIVES OF DISEASE IN CHILDHOOD
   
   F. Cools e M. Offringa, "Meta-analysis of elective high frequency ventilation in preterm infants with respiratory distress syndrome", ARCH DIS CH, 80(1), 1999, pp. F15-F20
9. OFFRINGA M
   EXCESS MORTALITY AFTER HUMAN ALBUMIN ADMINISTRATION IN CRITICALLY ILLPATIENTS (VOL 317, PG 223, 1998)
   BMJ. British medical journal
   
   M. Offringa, "EXCESS MORTALITY AFTER HUMAN ALBUMIN ADMINISTRATION IN CRITICALLY ILLPATIENTS (VOL 317, PG 223, 1998)", BMJ. British medical journal, 317(7161), 1998, pp. 786-786
10. OFFRINGA M
    CONSIDER VALIDITY, CLINICAL RELEVANCE, AND APPLICABILITY OF ALBUMIN FOR CRITICALLY ILL PATIENTS
    BMJ. British medical journal
    
    M. Offringa, "CONSIDER VALIDITY, CLINICAL RELEVANCE, AND APPLICABILITY OF ALBUMIN FOR CRITICALLY ILL PATIENTS", BMJ. British medical journal, 317(7154), 1998, pp. 343-343
11. OFFRINGA M
    EXCESS MORTALITY AFTER HUMAN ALBUMIN ADMINISTRATION IN CRITICALLY ILLPATIENTS
    BMJ. British medical journal
    
    M. Offringa, "EXCESS MORTALITY AFTER HUMAN ALBUMIN ADMINISTRATION IN CRITICALLY ILLPATIENTS", BMJ. British medical journal, 317(7153), 1998, pp. 223-224
12. VANESCH A; STEYERBERG EW; VANDUIJN CM; OFFRINGA M; DERKSENLUBSEN G; VANSTEENSELMOLL HA
    PREDICTION OF FEBRILE SEIZURES IN SIBLINGS - A PRACTICAL APPROACH
    European journal of pediatrics
    
    A. Vanesch et al., "PREDICTION OF FEBRILE SEIZURES IN SIBLINGS - A PRACTICAL APPROACH", European journal of pediatrics, 157(4), 1998, pp. 340-344
13. TIELVANBUUL MMC; KREMER LCM; OFFRINGA M; VOUTE PA; VANROYEN EA
    THE USE OF IN-111 ANTIMYOSINE SCINTIGRAPHY IN THE DETECTION OF EARLY HEART DAMAGE AFTER ANTHRACYCLINE THERAPY IN CHILDREN
    The Journal of nuclear medicine
    
    M.M.C. Tielvanbuul et al., "THE USE OF IN-111 ANTIMYOSINE SCINTIGRAPHY IN THE DETECTION OF EARLY HEART DAMAGE AFTER ANTHRACYCLINE THERAPY IN CHILDREN", The Journal of nuclear medicine, 39(5), 1998, pp. 212-212
14. BENBASSAT J; GERGAWI M; OFFRINGA M; BEARMAN JE; DRUKKER A
    VARIABILITY IN MANAGEMENT OF SYMPTOMLESS MICROHEMATURIA IN SCHOOLCHILDREN
    Postgraduate medical journal
    
    J. Benbassat et al., "VARIABILITY IN MANAGEMENT OF SYMPTOMLESS MICROHEMATURIA IN SCHOOLCHILDREN", Postgraduate medical journal, 74(869), 1998, pp. 161-164
15. BENBASSAT J; GERGAWI M; OFFRINGA M; DRUKKER A
    SYMPTOMLESS MICROHEMATURIA IN SCHOOLCHILDREN - CAUSES FOR VARIABLE MANAGEMENT STRATEGIES
    Quarterly Journal of Medicine
    
    J. Benbassat et al., "SYMPTOMLESS MICROHEMATURIA IN SCHOOLCHILDREN - CAUSES FOR VARIABLE MANAGEMENT STRATEGIES", Quarterly Journal of Medicine, 89(11), 1996, pp. 845-854
16. VANDENMOOTER G; OFFRINGA M; KALALA W; SAMYN C; KINGET R
    SYNTHESIS AND EVALUATION OF NEW LINEAR AZO-POLYMERS FOR COLONIC TARGETING
    STP pharma sciences
    
    G. Vandenmooter et al., "SYNTHESIS AND EVALUATION OF NEW LINEAR AZO-POLYMERS FOR COLONIC TARGETING", STP pharma sciences, 5(1), 1995, pp. 36-40
17. VANESCH A; VANSTEENSELMOLL HA; STEYERBERG EW; OFFRINGA M; HABBEMA JDF; DERKSENLUBSEN G
    ANTIPYRETIC EFFICACY OF IBUPROFEN AND ACETAMINOPHEN IN CHILDREN WITH FEBRILE SEIZURES
    Archives of pediatrics & adolescent medicine
    
    A. Vanesch et al., "ANTIPYRETIC EFFICACY OF IBUPROFEN AND ACETAMINOPHEN IN CHILDREN WITH FEBRILE SEIZURES", Archives of pediatrics & adolescent medicine, 149(6), 1995, pp. 632-637
18. VANESCH A; VANSTEENSELMOLL HA; STEYERBERG EW; OFFRINGA M; HABBEMA DJ; DERKSENLUBSEN A
    IBUPROFEN AND PARACETAMOL - EFFECTIVE ANTIPYRETICS IN CHILDREN WITH FEBRILE SEIZURES
    Pediatric research
    
    A. Vanesch et al., "IBUPROFEN AND PARACETAMOL - EFFECTIVE ANTIPYRETICS IN CHILDREN WITH FEBRILE SEIZURES", Pediatric research, 36(1), 1994, pp. 10000013-10000013
19. OFFRINGA M; BOSSUYT PM; DERKSENLUBSEN G; LUBSEN J
    PREDICTION OF SEIZURE RECURRENCE AFTER A FEBRILE SEIZURE
    Pediatric research
    
    M. Offringa et al., "PREDICTION OF SEIZURE RECURRENCE AFTER A FEBRILE SEIZURE", Pediatric research, 36(1), 1994, pp. 10000033-10000033
20. OFFRINGA M; BOSSUYT PMM; LUBSEN J; ELLENBERG JH; NELSON KB; KNUDSEN FU; ANNEGERS JF; ELRADHI ASM; HABBEMA JDF; DERKSENLUBSEN G; HAUSER WA; KURLAND LT; BANAJEH SMA; LARSEN S
    RISK-FACTORS FOR SEIZURE RECURRENCE IN CHILDREN WITH FEBRILE SEIZURES- A POOLED ANALYSIS OF INDIVIDUAL PATIENT DATA FROM 5 STUDIES
    The Journal of pediatrics
    
    M. Offringa et al., "RISK-FACTORS FOR SEIZURE RECURRENCE IN CHILDREN WITH FEBRILE SEIZURES- A POOLED ANALYSIS OF INDIVIDUAL PATIENT DATA FROM 5 STUDIES", The Journal of pediatrics, 124(4), 1994, pp. 574-584
21. VANESCH A; STEYERBERG EW; BERGER MY; OFFRINGA M; DERKSENLUBSEN G; HABBEMA JDF
    FAMILY HISTORY AND RECURRENCE OF FEBRILE SEIZURES
    Archives of Disease in Childhood
    
    A. Vanesch et al., "FAMILY HISTORY AND RECURRENCE OF FEBRILE SEIZURES", Archives of Disease in Childhood, 70(5), 1994, pp. 395-399
22. TISSING WJE; VANSTEENSELMOLL HA; OFFRINGA M
    SEVERITY OF RESPIRATORY SYNCYTIAL VIRUS-INFECTIONS AND IMMUNOGLOBULINCONCENTRATIONS
    Archives of Disease in Childhood
    
    W.J.E. Tissing et al., "SEVERITY OF RESPIRATORY SYNCYTIAL VIRUS-INFECTIONS AND IMMUNOGLOBULINCONCENTRATIONS", Archives of Disease in Childhood, 69(1), 1993, pp. 156-157